Revolutionizing molecular design with AI and physics

QuanMol is at the forefront of innovation in molecular design, utilizing the latest advancements in AI technology and a deep understanding of molecular physics to revolutionize the way we approach molecular design in key industries such as medicine, materials, and energy.

About us

Platform-driven service world

Leaders in AI-powered molecular design

QuanMol is a revolutionary company that specializes in providing cutting-edge solutions in molecular design using AI-powered technology. Founded in 2021, and based in the heart of Silicon Valley and Pasadena, we are dedicated to advancing the field of molecular design across industries including medicine, materials, and energy.


QuanMol offers a cutting-edge in-silico molecular discovery platform, designed to provide unparalleled solutions in the field of molecular design.

At QuanMol, we have developed a revolutionary in-silico discovery platform, QuanMol ReDefine, that utilizes a pioneering integration of physics-informed deep learning and state-of-the-art computational chemistry methods. This innovative approach enables us to provide unparalleled, out-of-the-box solutions for pharmaceutical development, allowing for faster and more accurate drug discovery and development. We have designed it to be user-friendly and accessible, making it easy for researchers and pharmaceutical companies to access and utilize the powerful tools it provides.With QuanMol ReDefine, we are bringing the future of molecular design within reach.


Accelerated molecular design

QuanMol Thinker

A revolutionary AI agent that empowers rational molecular design by providing unparalleled insights and decision-making capabilities.

QuanMol Unifier

A universal molecular representation platform that accurately predicts pharmaceutical properties, streamlining the drug development process.

QuanMol Navigator

A world-leading structure prediction engine for protein-ligand interactions, providing unparalleled accuracy and efficiency in identifying potential drug targets.

These products are the result of years of research and development, and are designed to provide researchers and pharmaceutical companies with the tools they need to make informed decisions and accelerate the drug discovery process.
QuanMol in the news
Join us
We are actively hiring experts in artificial intelligence, computational chemistry / biology, and beyond.